Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
AOD-9604
Max Weight Loss12.3%
Studies3
Participants78
StatusAvailable

AOD-9604

Human Growth Hormone Fragment 176-191

AOD-9604 is a modified fragment of human growth hormone (HGH) comprising amino acids 176-191 from the C-terminus. Developed by Metabolic Pharmaceuticals, this peptide specifically targets fat loss without the growth-promoting effects of full HGH. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation), making it a targeted approach for body composition improvement and weight management.

Clinical Benefits

Targeted fat loss without growth hormone side effects
Stimulates lipolysis in adipose tissue
Inhibits new fat formation (lipogenesis)
Preserves lean muscle mass during weight loss
No impact on blood sugar or insulin levels
Enhanced fat oxidation and metabolic rate

Mechanism of Action

AOD-9604 represents the last 16 amino acids (176-191) of the human growth hormone molecule, specifically the region responsible for fat metabolism without growth promotion. It binds to β3-adrenergic receptors on adipocytes, activating adenylyl cyclase and increasing cyclic adenosine monophosphate (cAMP) levels. This cascade activates hormone-sensitive lipase, promoting lipolysis (fat breakdown) while simultaneously inhibiting acetyl-CoA carboxylase, reducing lipogenesis (fat formation). The peptide mimics the natural fat-burning properties of HGH without affecting growth, insulin sensitivity, or IGF-1 production.

Key Action: Growth hormone fragment - stimulates fat breakdown while preserving muscle mass

Proven Results

%
Maximum Weight Loss
Clinical research data
0%
Diabetes Risk Reduction
Clinical research data
78
Total Participants
Research studies
0%
CV Risk Reduction
Clinical data

Medical Disclaimer

AOD-9604 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.